BiomX (PHGE) Invested Capital (2018 - 2023)
BiomX (PHGE) posted Invested Capital of $5.8 million for Q4 2023, up 3.64% sequentially from $5.6 million in Q3 2023, and up 35.1% YoY from $4.3 million in Q4 2022.
BiomX (PHGE) Invested Capital (2018 - 2023) Analysis & Trends
BiomX has reported Invested Capital for 6 years, with the latest figure at $5.8 million in Q4 2023.
- Quarterly Invested Capital rose 35.1% year-over-year to $5.8 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $5.8 million (down 71.74% YoY) and the FY2023 annual result came in at $5.8 million, up 35.1% from the prior year.
- Invested Capital grew to $5.8 million in Q4 2023 per PHGE's latest filing, from $5.6 million in the prior quarter.
- Over five years, Invested Capital peaked at $5.8 million in Q4 2023 and troughed at $361000.0 in Q1 2020.
- A 5-year average of $2.0 million and a median of $791000.0 in 2021 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2022 and 2023: Invested Capital declined 14.02% in 2022, then soared 712.52% in 2023.
- Over 5 years, Invested Capital stood at $375000.0 in 2019, then surged by 130.13% to $863000.0 in 2020, then decreased by 5.1% to $819000.0 in 2021, then jumped by 422.83% to $4.3 million in 2022, then surged by 35.1% to $5.8 million in 2023.
- According to Business Quant data, Invested Capital over the past three periods registered $5.8 million, $5.6 million, and $5.4 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | BiomX | 351,774.34 | -816,225.66 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5.79 Mn |
| Sep 30, 2023 | 5.58 Mn |
| Jun 30, 2023 | 5.39 Mn |
| Mar 31, 2023 | 5.22 Mn |
| Dec 31, 2022 | 4.28 Mn |
| Sep 30, 2022 | 687,000.00 |
| Jun 30, 2022 | 708,000.00 |
| Mar 31, 2022 | 790,000.00 |
| Dec 31, 2021 | 819,000.00 |
| Sep 30, 2021 | 799,000.00 |
| Jun 30, 2021 | 791,000.00 |
| Mar 31, 2021 | 763,000.00 |
| Dec 31, 2020 | 863,000.00 |
| Sep 30, 2020 | 594,000.00 |
| Jun 30, 2020 | 369,000.00 |
| Mar 31, 2020 | 361,000.00 |
| Dec 31, 2019 | 375,000.00 |
| Dec 31, 2018 | 50,000.00 |